Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

Marc Buyse, Pierre Squifflet, Beverly J. Lange, Todd A. Alonzo, Richard A. Larson, Jonathan E. Kolitz, Stephen L. George, Clara D. Bloomfield, Sylvie Castaigne, Sylvie Chevret, Didier Blaise, Dominique Maraninchi, Kathryn J. Lucchesi, Tomasz Burzykowski

Blood (2011) 117 (26): 7007–7013.

https://doi.org/10.1182/blood-2011-02-337725

Published: 2011

Includes: Supplemental data

Journal Articles

“One Hour” Rituximab Infusion Is Safe and Improves Patient Care and Outpatient Unit Management.

Thérèse Aurran-Schleinitz, Gwaenaelle Gravis, Martine Vittot, Diane Coso, Jérôme Rey, Jean-Marc Schiano, Aude Charbonnier, Emmanuelle Fougereau, Dominique Maraninchi, Reda Bouabdallah

Blood (2005) 106 (11): 4759.

https://doi.org/10.1182/blood.V106.11.4759.4759

Published: 2005

Journal Articles

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Anne-Marie Stoppa, MD, Norbert Vey, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Diane Coso, MD, Aude Charbonnier, MD, PhD, Jean Marc Schianno, MD, Therese Aurran, MD, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Marina Lafage, MD, PhD, Didier Blaise, MD, Jean Albert Gastaud, MD, Dominique Maraninchi, MD

Blood (2005) 106 (11): 2922.

https://doi.org/10.1182/blood.V106.11.2922.2922

Published: 2005

Journal Articles

Early Allogeneic Bone Marrow Transplantation for Young Adults with Acute Myeloid Leukemia in First Complete Remission: The 17 Year Experience of the BGMT Group.

Eric Jourdan, Jean-Michel Boiron, Nicole Dastugue, Norbert Vey, Gérald Marit, Françoise Rigal-Huguet, Lysiane Molina, Nathalie Fegueux, Arnaud Pigneux, Christian Recher, Jean-François Rossi, Michel Attal, Jean-Jacques Sotto, Dominique Maraninchi, Josy Reiffers, Valérie-Jeanne Bardou, Didier Blaise

Blood (2004) 104 (11): 619.

https://doi.org/10.1182/blood.V104.11.619.619

Published: 2004

Journal Articles

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Blood (2004) 103 (2): 435–441.

https://doi.org/10.1182/blood-2003-07-2236

Published: 2004

Journal Articles

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Mohamad Mohty, Jacques-Olivier Bay, Catherine Faucher, Bachra Choufi, Karin Bilger, Olivier Tournilhac, Norbert Vey, Anne-Marie Stoppa, Diane Coso, Christian Chabannon, Patrice Viens, Dominique Maraninchi, Didier Blaise

Blood (2003) 102 (2): 470–476.

https://doi.org/10.1182/blood-2002-12-3629

Published: 2003

Journal Articles

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

Didier Blaise, Dominique Maraninchi, Mauricette Michallet, Josy Reiffers, Jean Pierre Jouet, Noël Milpied, Agnes Devergie, Michel Attal, Jean Jacques Sotto, Mathieu Kuentz, Norbert Ifrah, Charles Dauriac, Pierre Bordigoni, Nicole Gratecos, François Guilhot, Denis Guyotat, Eliane Gluckman, Jean Paul Vernant

Blood (2001) 97 (11): 3669–3671.

https://doi.org/10.1182/blood.V97.11.3669

Published: 2001

NARROW

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

“One Hour” Rituximab Infusion Is Safe and Improves Patient Care and Outpatient Unit Management.

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Early Allogeneic Bone Marrow Transplantation for Young Adults with Acute Myeloid Leukemia in First Complete Remission: The 17 Year Experience of the BGMT Group.

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

Email alerts

ASH Publications

American Society of Hematology

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia

“One Hour” Rituximab Infusion Is Safe and Improves Patient Care and Outpatient Unit Management.

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Early Allogeneic Bone Marrow Transplantation for Young Adults with Acute Myeloid Leukemia in First Complete Remission: The 17 Year Experience of the BGMT Group.

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only